20 results about "Neural regeneration" patented technology

The invention belongs to the field of biomedical engineering, and particularly relates to an amino acid modified molybdenum disulfide artificial extracellular matrix and application. Preparing an amino acid modified molybdenum disulfide artificial extracellular matrix, inoculating the neuron in-vitro model PC12 cell suspension onto the artificial extracellular matrix, and constructing the nerve cell in-vitro differentiation model. The artificial extracellular matrix with good biocompatibility is obtained by constructing different kinds of amino acid modified molybdenum disulfide nano material artificial extracellular matrixes as the artificial extracellular matrix of nerve cells PC12, and the artificial extracellular matrix improves the activity of the PC12 cells and promotes the differentiation of nerve cell synapses; a neuron in-vitro model with high differentiation and higher activity is constructed, and the artificial extracellular matrix can be used for nerve regeneration and neural engineering.

A method of activating a piezoelectric neuroconduit guide scaffold including a plurality of aligned piezoelectric polymer nanofibers, the method including mechanically stimulating the piezoelectric neuroconduit guide scaffold with hydro-acoustic waves or shockwaves to remotely activate a piezoelectric effect of the nanofibrous scaffolds that induces a mechano-electrical stimulus on neural cells cultured on the scaffold, wherein the mechano-electrical stimulus promotes nerve fiber outgrowth from the neuronal cells. Some aspects relate to seeding individual components of neural tissues on the piezoelectric neuroconduit guide scaffold, wherein the hydro-acoustic stimulation induces neural tissue formation. In other aspects, the piezoelectric neuroconduit guide scaffold is implanted in a damaged neural tissue, wherein stimulating the piezoelectric neuroconduit guide scaffold by the application of shockwaves promotes nerve fiber outgrowth that bridges a nerve gap to induce nerve regeneration or reinnervation of the damaged neural tissue.

The invention relates to the technical field of biomedicine, and discloses an application of a light-driven organic semiconductor nano motor in preparation of a product for promoting differentiation of neural stem cells, and the organic semiconductor nano motor is obtained by carrying out surface treatment on poly (3-hexylthiophene) through lauryl sodium sulfate and normal propyl alcohol. In-vivo experiments find that in-situ injection of the P3HT nanomotor in a subventricular region (V-SVZ) of a mouse can maintain stable photoresponse performance under visible light irradiation, and can promote directional differentiation of neural stem cells to a neural pedigree (rather than glial cells). In addition, the organic semiconductor nano motor has good cytocompatibility and systemic biological safety, and has a good application prospect in the field of nerve regeneration medicine.

Use of a TGF-β small molecule inhibitor in the field of nerve regeneration, for in vitro regeneration and directed differentiation of a variety of nerve cells and brain-like organs. By adding the TGF-β small molecule inhibitor to a set of basal media having clear chemical compositions, pluripotent stem cells can be induced into adult cells derived from a variety of neural stem cells, and the number of induced nerve cells can be greatly increased.

The invention provides a molecular self-assembly integrin patch for regulating and controlling mechanical signals of cells as well as a preparation method and application of the molecular self-assembly integrin patch, and an extracellular matrix (ECM) bionic cell patch is constructed through a molecular self-assembly technology. According to the patch, a laminin-derived integrin binding ligand is extended and self-assembled through an N-terminal aromatic amino acid to form a fibrous nano network, and the patch has controllable nano-scale ligand distribution, network viscoelasticity and stability, and can specifically activate integrin beta1 at the top end of MSC (mesenchymal stem cell), so that a mechanical signal is conducted from a cell membrane to a cell nucleus. The process coordinates cytoskeleton reconstruction, nuclear deformation and chromatin rearrangement, and finally drives the MSC to efficiently differentiate into neuron-like cells under the condition of no exogenous gene or chemical induction, so as to express nerve markers such as TUBB3 and present functional characteristics such as spontaneous calcium transient. The cell patch can be widely applied to nerve regeneration, tissue engineering, disease model construction and intelligent biological material development.

The invention discloses a combined cell transplantation system for Huntington's disease treatment, a preparation method and application. The invention belongs to the technical field of biomedicine, and aims at solving the problems that when an existing stem cell transplantation technology is used for treating the Huntington's disease (HD), the graft survival rate is low, differentiation uncertainty is high, and integration with a host neural network is difficult. The combined cell transplantation system for treating the Huntington's disease comprises human umbilical cord mesenchymal stromal cells (hUC-MSCs) and striatum organoid (hStrOs), the human umbilical cord mesenchymal stromal cells play a role in immunoregulation and provide endogenous immune microenvironment support, and the human umbilical cord mesenchymal stromal cells play a role in immunoregulation and provide endogenous immune microenvironment support; the striatum organ takes medium spinous projective neurons (MSNs) for expressing DARPP-32 and CTIP-2 as a main body, and undertakes a cell replacement function. The HD cell therapy is promoted to be converted from a traditional single cell replacement mode to an'immune regulation-nerve regeneration 'multi-dimensional functional remodeling mode through cooperation of the HD cell therapy and the Huntington's disease, and a new way is provided for cell therapy of the Huntington's disease.

The invention discloses a composition, a culture medium composition and a method for efficiently and stably inducing differentiation of cortical brain organoid. The composition is prepared from lithium calcium silicate, Y-27632, SB431542, LDN193189, FGF2, EGF, BDNF, NT-3 and Matrigel. According to the invention, lithium calcium silicate (LCS) is innovatively introduced as a novel bioactive material, and the cortex purity, the structural polarity, the progenitor cell maintenance and the functional maturity of the organoid can be remarkably improved through the slow-release ion effect (such as Li, Ca and SiO) of the LCS in a culture system in cooperation with a stage-specific signal channel regulation and control and a serum-free culture system. According to the invention, the brain organ with high-purity cortical characteristics, good structural texture and functional maturity can be obtained, and a new technical solution is provided for transplantation materials for cerebral arterial thrombosis disease mechanism research, drug screening evaluation and nerve regeneration treatment.

The application discloses a nerve regeneration guide conduit for promoting nerve cell differentiation and a preparation method and application thereof. The nerve regeneration guide conduit can realize stable and long-acting release of bioactive factors, effectively reduce the risk of tissue adhesion, efficiently induce nerve cell differentiation, promote axon growth and function recovery, and provides a novel and effective solution for nerve regeneration and repair. In addition, the nerve regeneration guide conduit has excellent conductivity, biocompatibility, mechanical adaptability and the like, and therefore has a wide application prospect in the field of nerve regeneration and repair.

The invention relates to a neural stem cell-parathymosin composite cell preparation and application thereof in treatment of nerve injury diseases. According to the invention, it is found for the first time that neural stem cells overexpressing parathymosin (PTMS) can effectively promote neuron neogenesis and axon growth in in-vitro and in-vivo experiments; animal experiment results show that the traditional Chinese medicine composition can also be used as a treatment means for promoting nerve regeneration to resist dyskinesia related to nerve injury diseases.

The invention provides an implantable artificial nerve and a preparation method thereof, and belongs to the field of biomedical engineering and neural restoration. Comprising a signal coupling interface, the signal coupling interface is used for being connected with broken nerves, the signal coupling interface is further used for forming interface impedance lower than 500 omega.cm < 2 > under the condition that conversion impedance between biological ion current and artificial electron current is 1 kHz, and the signal coupling interface is further filled with neurotrophic factors; the conduction unit is connected with the signal coupling interface, and the conduction unit is filled with neurotrophic factors; the bionic microvessel channel is arranged in the conduction unit, and the bionic microvessel channel is used for conveying a nutrient solution or guiding revascularization. The method aims at solving the problems that an existing neural restoration technology is low in signal conversion efficiency, passive in nerve regeneration guiding mode and the like. The device has the technical effects that efficient signal conversion is realized, and a microenvironment beneficial to regeneration can be actively created.

An injectable, self-healing hydrogel, its preparation method, and its applications. This invention belongs to the field of biomedical engineering and neural regeneration, specifically relating to a hydrogel, its preparation method, and its applications. This invention provides an injectable, self-healing hydrogel for carrying neural stem cells based on Schiff base crosslinking. This hydrogel achieves self-healing and injectability through dynamic Schiff base bonds. A reversible imine bond crosslinking structure is formed through the Schiff base reaction between amino and aldehyde groups, exhibiting good biocompatibility and structural stability. The surface of biological tissue is rich in amino and hydroxyl groups, which can react again with the aldehyde groups in the OHA to form a dynamic covalent crosslinking network. Through interfacial Schiff base bonding, electrostatic attraction, and hydrogen bonding, this hydrogel can achieve strong wet adhesion to biological tissue and form a stable scaffold at the site of brain injury. Simultaneously, the nanospheres in the system can achieve sustained release of growth factors, effectively promoting the survival, proliferation, and differentiation of neural stem cells, ultimately achieving precise repair and functional recovery of neural tissue.

The application belongs to the field of biomedical engineering, and particularly relates to an amino acid modified molybdenum disulfide artificial extracellular matrix and application. The amino acid modified molybdenum disulfide artificial extracellular matrix is prepared, neuron in vitro model PC12 cell suspension is inoculated on the artificial extracellular matrix, and a nerve cell in vitro differentiation model is constructed. The application constructs different kinds of amino acid modified molybdenum disulfide nanomaterial artificial extracellular matrix for nerve cell PC12 cell artificial extracellular matrix, obtains artificial extracellular matrix with good biocompatibility, the artificial extracellular matrix improves PC12 cell activity and promotes differentiation of nerve cell synapse, constructs a neuron in vitro model with high differentiation and higher activity, and the artificial extracellular matrix can be used for nerve regeneration and nerve engineering.

The invention provides a biological scaffold with a piezoelectric effect as well as a preparation method and application of the biological scaffold. According to the invention, bismuth titanate (Bi4Ti3O12) nanosheets with excellent piezoelectric properties are compounded with poly-L-lactic acid (PLLA) with better biocompatibility through an electrostatic spinning technology for the first time, a novel bionic nervous tissue engineering scaffold is developed, the scaffold has degradability and excellent biocompatibility and safety, the flexibility of the scaffold is improved, and the scaffold can be applied to the field of biological engineering. The defects of high inherent hardness, high brittleness, non-degradability and cytotoxicity of an inorganic piezoelectric material are overcome. The PLLA / Bi4Ti3O12 composite scaffold provided by the invention can significantly promote neuronal differentiation of neural stem cells, inhibits directional differentiation of glial cell lineages while enhancing neuronal differentiation, can be used as an advanced nerve regeneration interface in nervous tissue engineering, provides a very potential strategy for neural circuit reconstruction and functional recovery, and has a wide application prospect. And a new direction is developed for neural restoration and treatment of neurodegenerative diseases.

The invention discloses a method for inducing and converting mesenchymal cells into neural stem cells, which relates to the technical field of biology and comprises the following steps: (a) providing a group of mesenchymal stem cells cultured in vitro; (b) culturing the mesenchymal stem cells in an induction medium, and inducing the mesenchymal stem cells to differentiate into neural stem cells; wherein the induction medium comprises a basal medium and the following components in effective induction concentrations: a histone deacetylase inhibitor (HDAC inhibitor); a glycogen synthase kinase-3beta inhibitor (GSK-3beta inhibitor); a retinoic acid receptor agonist; the invention provides a set of technical scheme for inducing and transforming the mesenchymal stem cells into the neural stem cells for the first time, which is clear in components, efficient, stable, high in universality and simple and convenient to operate, not only fills the blank in the prior art, but also provides a new cell source and technical support for medical research and clinical treatment of nerve regeneration. The method has an important scientific research value and a wide application prospect.

This disclosure provides novel and innovative compositions of neuronal regeneration-promoting cells (NRPCs), methods for generating NRPCs, and methods for treating subjects having damaged nerve cells using NRPCs. In one embodiment, the NRPCs are derived from tonsil-derived mesenchymal stem cells and express CD26, CD106, CD112, CD121a, and CD141, where CD121a has an expression level of approximately 30% or higher, and this expression level is measured immediately after thawing the NRPCs from a thawed state. Furthermore, the NRPCs are configured to promote axon formation on neuronal cells.

The invention relates to a polypeptide and application thereof, and belongs to the technical field of biomedical treatment. The amino acid sequence of the polypeptide comprises a sequence as shown in SEQ ID NO. 1. The invention designs a novel polypeptide, verifies that the novel polypeptide can relieve the inhibition effect of myelin protein molecules and promote the neural stem cells to differentiate into neurons, discovers that the novel polypeptide can be combined with a microtubule stabilizer TPI-287 to promote the neural stem cells to differentiate into neurons, and further develops a product and a method for promoting the neural stem cells to differentiate into neurons. The method is of great significance in promoting nerve regeneration medicine to span from basic research to clinical practice.

The invention discloses acellular matrix double-network hydrogel as well as a preparation method and application thereof. Specifically, the invention provides the acellular matrix double-network hydrogel, the acellular matrix double-network hydrogel is provided with a first network formed by thermal gelation of an acellular matrix and a second network formed by (methyl) acryloylated gelatin, and the first network and the second network are interspersed to form the double-network hydrogel. The hydrogel has excellent biocompatibility, controllable physical properties and active biological signal regulation and control capability, can be used as a platform material, and has excellent application prospects in the fields of tissue repair and regenerative medicine, especially in the aspects of nerve regeneration and stem cell proliferation and induced differentiation.

Embodiments disclose systems and apparatus that provide neurogenesis activation by FUS stimulation including activating quiescent NSCs in the subventricular zone of the lateral ventricles and promoting the proliferation of NSCs and subsequent differentiation into newly regenerated neurons. Also disclosed is a conventional MRI guided tFUS system programmed for use with ultrasonic activation of NSCs. A wireless electronic driving configuration for transcranial use under MRI guidance is provided and a cylindrically distributed ultrasound transducer array design to provide increased steering range in at least two axes. A close integration of tFUS with MRI navigation, achieved by a novel wearable thin-film MRI coil array tightly integrated with the transducer array, enables full navigation performance of MRI in real time during FUS treatment.

This invention relates to the field of cell dedifferentiation, and more particularly to a method for promoting the dedifferentiation of satellite glial cells into neural stem cell-like cells. First, a three-dimensional composite hydrogel of nervonic acid-modified chitosan is constructed. Then, satellite glial cells are seeded and cultured in this hydrogel, inducing dedifferentiation to obtain a cell population with a neural stem cell-like phenotype. The hydrogel constructs a basic network through covalently linked amide bonds between nervonic acid and chitosan, and utilizes the hydrophobic association domains formed by the long-chain alkyl groups of nervonic acid to self-assemble into a covalently cross-linked + hydrophobically associated dual network structure. This simulates the softness, deformability, and local mechanical gradient properties of the neural tissue microenvironment, providing ideal dedifferentiation conditions for satellite glial cells to differentiate into neural stem cell-like cells. During the dedifferentiation process, markers such as Nestin, SOX2, and PAX6 are expressed, showing promising applications in neural regeneration, disease model construction, and cell therapy.